BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 1542917)

  • 1. Paired comparison of platelet concentrates prepared from platelet-rich plasma and buffy coats using a new technique with 111In and 51Cr.
    Keegan T; Heaton A; Holme S; Owens M; Nelson E; Carmen R
    Transfusion; 1992 Feb; 32(2):113-20. PubMed ID: 1542917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of the quality of hemoderivatives obtained using a buffy-coat extraction system with a top-and-bottom technique (Optipress II)].
    Hurtado C; Bonanad S; Soler MA; Mirabet V; Blasco I; Planelles MD; de Miguel A
    Sangre (Barc); 1999 Oct; 44(5):319-26. PubMed ID: 10618907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods.
    Singh RP; Marwaha N; Malhotra P; Dash S
    Asian J Transfus Sci; 2009 Jul; 3(2):86-94. PubMed ID: 20808653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the platelet-rich plasma and buffy coat protocols for preparation of canine platelet concentrates.
    Hoareau GL; Jandrey KE; Burges J; Bremer D; Tablin F
    Vet Clin Pathol; 2014 Dec; 43(4):513-8. PubMed ID: 25267468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival in vivo of platelets stored for 48 hours in the buffycoat at 4 degrees C compared to platelet rich plasma stored at 22 degrees C.
    Pietersz RN; Loos JA; Reesink HW
    Blut; 1987 Apr; 54(4):201-6. PubMed ID: 3828537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Qualitative comparison between buffy-coat-collected platelet concentrates and those by single-donor plateletpheresis].
    Yu Y; Luo Q; Liu JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):878-81. PubMed ID: 17708824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent label method with 111In and 51Cr allows accurate evaluation of platelet viability of stored platelet concentrates.
    Holme S; Heaton A; Roodt J
    Br J Haematol; 1993 Aug; 84(4):717-23. PubMed ID: 8217832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood fractionation based on the extraction of the buffy-coat layer. Analysis of our results].
    Algora M; Torres P; Rodríguez MA; de la Calle C; Biurrún M; Nieto S; Ruiz M; Alonso MV
    Sangre (Barc); 1995 Apr; 40(2):91-6. PubMed ID: 7784953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).
    Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A
    Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vivo evaluation of random donor platelet concentrates from pooled buffy coats.
    Klüter H; Dörges L; Maass E; Wagner T; Bartels H; Kirchner H
    Ann Hematol; 1996 Aug; 73(2):85-9. PubMed ID: 8774617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White cell-reduced platelet concentrates prepared by in-line filtration of platelet-rich plasma.
    Sweeney JD; Holme S; Heaton WA; Nelson E
    Transfusion; 1995 Feb; 35(2):131-6. PubMed ID: 7825208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation of leukocyte-reduced platelet concentrates from buffy coats using a novel separation apparatus].
    Müller N; Krüssel H
    Beitr Infusionsther Transfusionsmed; 1994; 32():52-4. PubMed ID: 9480156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of acetate during platelet storage in a synthetic medium.
    Bertolini F; Murphy S; Rebulla P; Sirchia G
    Transfusion; 1992 Feb; 32(2):152-6. PubMed ID: 1542920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
    Pietersz RN
    Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
    Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G
    Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low leukocyte contamination without filtration by preparation of platelet concentrates in cylindrical bags with the buffy-coat method.
    Kostelijk EH; Loos JA; Veldman HA; de Korte D
    Vox Sang; 2000; 79(2):87-93. PubMed ID: 11054046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
    Ali SF
    Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo properties of various types of platelets.
    Rebulla P
    Vox Sang; 1998; 74 Suppl 2():217-22. PubMed ID: 9704448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Storage of single donor platelet concentrates: paired comparison of storage as single or double concentrates.
    Glaser A; Friedlein H; Zingsem J; Zimmermann R; Weisbach V; Ruf A; Eckstein R
    J Clin Apher; 2001; 16(3):148-54. PubMed ID: 11746543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of leukocyte contamination on storage of platelet concentrates from buffy coats].
    Klüter H; Klinger M; Bauhaus M; Kirchner H
    Beitr Infusionsther Transfusionsmed; 1994; 32():61-5. PubMed ID: 9480159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.